Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy

Influenza viruses affect millions of people worldwide on an annual basis. Although vaccines are available, influenza still causes significant human mortality and morbidity. Vaccines target the major influenza surface glycoprotein hemagglutinin (HA). However, circulating HA subtypes undergo continual variation in their dominant epitopes, requiring vaccines to be updated annually. A goal of next-generation influenza vaccine research is to produce broader protective immunity against the different types, subtypes, and strains of influenza viruses. One emerging strategy is to focus the immune response away from variable epitopes, and instead target the conserved stem region of HA. To increase the display and immunogenicity of the HA stem, nanoparticles are being developed to display epitopes in a controlled spatial arrangement to improve immunogenicity and elicit protective immune responses. Engineering of these nanoparticles requires structure-guided design to optimize the fidelity and valency of antigen presentation. Here, we review electron microscopy applied to study the 3D structures of influenza viruses and different vaccine antigens. Structure-guided information from electron microscopy should be integrated into pipelines for the development of both more efficacious seasonal and universal influenza vaccine antigens. The lessons learned from influenza vaccine electron microscopic research could aid in the development of novel vaccines for other pathogens.

• Publication year

  2018

• Venue

  Vaccines

• Publication date

  2018-05-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/vaccines6020031PMID 29799445PMCID 6027289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Live attenuated influenza vaccine.

  2020cited by this paper
• A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

  2018cited by this paper
• Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.

  2018cited by this paper
• Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.

  2018cited by this paper
• Evolution of a designed protein assembly encapsulating its own RNA genome

  2017cited by this paper
• The Pathway to a Universal Influenza Vaccine.

  2017cited by this paper
• Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines

  2017cited by this paper
• M2-based influenza vaccines: recent advances and clinical potential

  2017cited by this paper
• Immune history and influenza virus susceptibility.

  2017cited by this paper
• Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes

  2017cited by this paper
• Structural studies of influenza virus RNPs by electron microscopy indicate molecular contortions within NP supra-structures.

  2017cited by this paper
• Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments

  2017cited by this paper
• The Doctrine of Original Antigenic Sin: Separating Good From Evil

  2017cited by this paper
• Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform.

  2017cited by this paper
• Phantoms models to characterize influenza hemagglutinin-based vaccines

  2017cited by this paper
• Quantifying B cells capable of producing broadly neutralizing antibodies against influenza serves as a metric to guide the development of a universal influenza vaccine

  2016cited by this paper
• Design of a hyperstable 60-subunit protein icosahedron

  2016cited by this paper
• Filamentous Influenza Viruses

  2016cited by this paper
• Visualization and Sequencing of Membrane Remodeling Leading to Influenza Virus Fusion

  2016cited by this paper
• Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms

  2016cited by this paper
• Accurate design of megadalton-scale two-component icosahedral protein complexes

  2016cited by this paper
• Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

  2016cited by this paper
• Single-particle cryo-EM data acquisition by using direct electron detection camera.

  2016cited by this paper
• Cryo-electron microscopy of influenza vaccine nanoparticles indicates full occupancy of displayed epitopes is facilitated by particle design

  2016cited by this paper
• Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting

  2016cited by this paper
• The hemifusion structure induced by Influenza virus haemagglutinin is determined by physical properties of the target membranes

  2016cited by this paper
• Antibodies with ‘Original Antigenic Sin’ Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses

  2016cited by this paper
• Structural Snapshots of Influenza Virus Membrane Fusion by Cryomicroscopy

  2016cited by this paper
• Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate

  2016cited by this paper
• HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions.

  2016cited by this paper
• Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

  2016cited by this paper
• Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.

  2016cited by this paper
• Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact

  2016cited by this paper
• Filamentous influenza viruses.

  2016cited by this paper
• Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles

  2016cited by this paper
• Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

  2015cited by this paper
• Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies.

  2015cited by this paper
• Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

  2015cited by this paper
• A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen

  2015cited by this paper
• Raising expectations for subunit vaccine.

  2015cited by this paper
• The development of cryo-EM into a mainstream structural biology technique

  2015cited by this paper
• FDA approves Gardasil 9 for more types of HPV

  2015influential reference
• Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)

  2015cited by this paper
• Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

  2015cited by this paper
• Viral receptor-binding site antibodies with diverse germline origins.

  2015cited by this paper
• Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy.

  2015cited by this paper
• Bat-derived influenza-like viruses H17N10 and H18N11

  2014cited by this paper
• Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus

  2014cited by this paper
• The Temperature-Sensitive and Attenuation Phenotypes Conferred by Mutations in the Influenza Virus PB2, PB1, and NP Genes Are Influenced by the Species of Origin of the PB2 Gene in Reassortant Viruses Derived from Influenza A/California/07/2009 and A/WSN/33 Viruses

  2014cited by this paper
• Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge

  2014cited by this paper
• The M Segment of the 2009 Pandemic Influenza Virus Confers Increased Neuraminidase Activity, Filamentous Morphology, and Efficient Contact Transmissibility to A/Puerto Rico/8/1934-Based Reassortant Viruses

  2014cited by this paper
• Morphology of Influenza B/Lee/40 Determined by Cryo-Electron Microscopy

  2014cited by this paper
• Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

  2014cited by this paper
• In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen

  2014cited by this paper
• Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy

  2014cited by this paper
• Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

  2014cited by this paper
• Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in Ferrets

  2014cited by this paper
• Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.

  2014cited by this paper
• Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.

  2014cited by this paper
• Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site

  2013cited by this paper
• Spherical Influenza Viruses Have a Fitness Advantage in Embryonated Eggs, while Filament-Producing Strains Are Selected In Vivo

  2013cited by this paper
• A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin

  2013cited by this paper
• Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization

  2013cited by this paper
• Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

  2013cited by this paper
• H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge

  2013cited by this paper
• HIV-1 Envelope Glycoprotein Trimers Display Open Quaternary Conformation When Bound to the gp41 Membrane-Proximal External-Region-Directed Broadly Neutralizing Antibody Z13e1

  2013cited by this paper
• Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies

  2013cited by this paper
• Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium

  2013cited by this paper
• Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

  2013influential reference
• MANUFACTURING PROCESS-I

  2013cited by this paper
• Cryotomography of Budding Influenza A Virus Reveals Filaments with Diverse Morphologies that Mostly Do Not Bear a Genome at Their Distal End

  2013cited by this paper
• At Low pH, Influenza Virus Matrix Protein M1 Undergoes a Conformational Change Prior to Dissociating from the Membrane

  2013cited by this paper
• Traditional and New Influenza Vaccines

  2013cited by this paper
• Understanding and learning from the success of prophylactic human papillomavirus vaccines

  2012cited by this paper
• Rational immunogen design to target specific germline B cell receptors

  2012cited by this paper
• Structural Changes in Influenza Virus at Low pH Characterized by Cryo-Electron Tomography

  2012cited by this paper
• A Negative Stain for Electron Microscopic Tomography

  2012cited by this paper
• Highly Conserved Protective Epitopes on Influenza B Viruses

  2012cited by this paper
• A review of clinical trials of human papillomavirus prophylactic vaccines.

  2012cited by this paper
• Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.

  2012cited by this paper
• Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses

  2012cited by this paper
• Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

  2011cited by this paper
• Eurasian-Origin Gene Segments Contribute to the Transmissibility, Aerosol Release, and Morphology of the 2009 Pandemic H1N1 Influenza Virus

  2011cited by this paper
• Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.

  2011cited by this paper
• Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures

  2011cited by this paper
• A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

  2011cited by this paper
• Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.

  2011cited by this paper
• Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.

  2011cited by this paper
• Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

  2011cited by this paper
• The need for quadrivalent vaccine against seasonal influenza.

  2010cited by this paper
• Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza

  2010cited by this paper
• Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

  2010cited by this paper
• Structural organization of a filamentous influenza A virus

  2010cited by this paper
• Antibody Recognition of a Highly Conserved Influenza Virus Epitope

  2009influential reference
• Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha.

  2008cited by this paper
• Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.

  2008cited by this paper
• Molecular architecture of native HIV-1 gp120 trimers

  2008cited by this paper
• The biology of influenza viruses.

  2008cited by this paper
• Macromolecular modeling with rosetta.

  2008cited by this paper
• FluBlok, a recombinant hemagglutinin influenza vaccine

  2008cited by this paper

• Sialic Acids in Health and Disease

  2025cites this paper
• Production and compositional analysis of full-length influenza virus hemagglutinin in Nanodiscs: Insights from multi-angle light scattering.

  2024cites this paper
• Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protection

  2024cites this paper
• Polymeric nanoparticle-based mRNA vaccine is protective against influenza virus infection in ferrets

  2024cites this paper
• Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies

  2023cites this paper
• A guide into the world of high-resolution 3D imaging: the case of soft X-ray tomography for the life sciences

  2022cites this paper
• Commercial influenza vaccines vary in both the structural arrangements of HA complexes and in induction of antibodies to cross-reactive HA epitopes

  2022cites this paper
• Predicting epitopes for vaccine development using bioinformatics tools

  2022cites this paper
• Correlative imaging using super‐resolution fluorescence microscopy and soft X‐ray tomography at cryogenic temperatures provides a new way to assess virosome solutions for vaccine development

  2021cites this paper
• A public broadly neutralizing antibody class targets a membrane-proximal anchor epitope of influenza virus hemagglutinin

  2021cites this paper
• An overview of the recent advances in cryo-electron microscopy for life sciences.

  2021cites this paper
• B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

  2021cites this paper
• Cryo‐Electron Microscopy in Drug Discovery and Development: Opportunities and Challenges

  2021cites this paper
• Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance

  2021cites this paper
• Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges

  2021cites this paper
• ANALISIS BIOINFORMATIKA DAN EKSPRESI PROTEIN REKOMBINAN HEMAGGLUTININ DOMAIN GLOBULAR DARI VIRUS H5N1 INDONESIA PADA Escherichia coli BL21 (DE3) SEBAGAI KOMPONEN VAKSIN SUBUNIT INFLUENZA

  2021cites this paper
• Cryo-EM cools down swine fever

  2020cites this paper
• Viral surface geometry shapes influenza and coronavirus spike evolution through antibody pressure

  2020cites this paper
• Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus.

  2020cites this paper
• Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program

  2020cites this paper
• Separation of influenza virus‐like particles from baculovirus by polymer‐grafted anion exchanger

  2020cites this paper
• Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells

  2020cites this paper
• Influenza Vaccines toward Universality through Nanoplatforms and Given by Microneedle Patches

  2020cites this paper
• Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus.

  2020cites this paper
• Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases

  2019cites this paper
• Immunoelectron Microscopy of Viral Antigens

  2019cites this paper
• Pola Perubahan Urutan Asam Amino pada Hemaglutinin Virus H5N1 Indonesia

  2019cites this paper
• The Future of Influenza Vaccines: A Historical and Clinical Perspective

  2018cites this paper